Respiratory Motion and Corestone Biosciences to form JV in China

US-based ventilation monitoring firm Respiratory Motion and Chinese firm Corestone Biosciences have signed an agreement to form a joint venture (JV) company in China.

Free Report

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.

By GlobalData

By downloading this case study, you acknowledge that GlobalData may share your information with GlobalData and that your personal data will be used as described in their Privacy Policy Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The JV is set to provide new respiratory volume monitors that will be designed based on Respiratory Motion’s ExSpiron platform.

Intended to cater to the Chinese, as well as other international markets, the JV will additionally offer new critical care solutions for hospital and home care segments.

Corestone Biosciences chairman Weiping Yang said: “The establishment of this joint venture with CorestoneBio comes at a time of growing demand for respiratory solutions in China and globally.

“Respiratory Motion is an ideal partner in our efforts to meet the demand of physicians in China who have been waiting for a product that can reliably identify and continuously monitor respiratory compromise.”

“ExBMS is developed for accurate and reliable measurement of patient respiration, eliminating the need for calibration.”

Apart from the ExSpiron Basic Monitoring Software (ExBMS) for non-invasive respiratory measurement, Respiratory Motion will contribute its expertise in the development of high-tech monitoring platforms.

ExBMS is developed for accurate and reliable measurement of patient respiration, eliminating the need for calibration.

Respiratory Motion expects that the collaboration will result in enhanced manufacturing capabilities, product offerings and global expansion.

JV company CEO Francis Cao said: “Combining the resources of Corestone Biosciences and Respiratory motion will enable us to deliver an accelerated product launch and become a leading provider of novel respiratory and other healthcare solutions in China and worldwide.”